To mark World Multiple Sclerosis Day, we’re taking the opportunity to look back on some of the highlights in the field so far this year.
Browsing: Demyelinating disease
In this NCTalks podcast, we speak to Jens Kuhle to find out more about his work on monitoring multiple sclerosis using blood neurofilament light protein.
The National Institute for Health and Care Excellence (NICE) has recommended the use of four out of six disease-modifying therapies in relapsing–remitting multiple sclerosis.
This week, our industry report covers neuroblastoma, DUB inhibitors for neurodegenerative diseases and pediatric multiple sclerosis.
Scientists reveal that a molecule normally used by the immune system to prevent excessive damage may actually contribute to chronic white matter injury.
Robert Fox chats to Lauren Pulling about ibudilast in progressive MS, including the current landscape and potential treatment regimens.
This week, the American Academy of Neurology (CA, USA) presented findings from two studies that investigate the impact of ocrelizumab in multiple sclerosis patients.
In this week’s industry news round-up, we’ve chosen the latest updates from a wide range of disorders extending from depression to multiple sclerosis.
Alexander Rae-Grant chats to Lauren Pulling about the new guideline for multiple sclerosis treatment and how it will affect treatment practice in the field.
Clinical trial announcements, orphan-drug designation and more: check out our round-up of the biggest news from the neuroscience and neurology industries this week.